# To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

> **NCT02117141** · PHASE1 · COMPLETED · sponsor: **Zogenix, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HC-ER 20 mg capsule (fasted)
- **DRUG:** HC-ER 20 mg capsule (fed)

## Key facts

- **NCT ID:** NCT02117141
- **Lead sponsor:** Zogenix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117141, "To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02117141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*